NSE: SANOFI | BSE: 500674

Mid-range Performer

Download real time

4036.80 27.00 (0.67%)

Near 52W Low of ₹3976.00

12,031 NSE+BSE Volume

NSE 13 Feb, 2026 3:31 PM (IST)

9,297

Market Cap

High in industry

Beta 1Year

Very Low volatility

Sanofi India Ltd. share price target and research reports

Name: Latest research reports of Sanofi India Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Sanofi India Ltd.
Rating: 3
Author: ICICI Securities Limited

Latest analyst research reports with target prices and PDF download for SANOFI, BSE:500674 Sanofi India Ltd.

Search Inside the pdf :

Sanofi India Ltd.

14 Aug 2023, 12:00AM

4036.80

0.67%

Exports run the show

Hold: Sanofi India Ltd.

Recommendation Target

ICICI Securities Limited

Sanofi’s Q2CY23 result was boosted by solid traction in exports (up 30% YoY and ~25% of Q2 revenue), while domestic business took a back seat. Mandated price cuts of ~25% in Lantus (~25% of India sales) and other products under NLEM (15% of portfolio) may have dragged India growth by ~6% YoY, in our view.

Number of FII/FPI investors decreased from 164 to 149 in Dec 2025 qtr

Sanofi India Ltd.

20 May 2023

4036.80

0.67%

Sanofi India

Buy: Sanofi India Ltd.

Target

Sharekhan

Sanofi has lost -20.47% in the last 6 Months

Sanofi India Ltd.

27 Feb 2023

4036.80

0.67%

Sanofi India

Hold: Sanofi India Ltd.

Target

ICICI Direct

Sanofi India Ltd. is trading below all available SMAs

Sanofi India Ltd.

04 Nov 2022

4036.80

0.67%

Weak performance, but healthy margins

Buy: Sanofi India Ltd.

Recommendation Target

ICICI Securities Limited

Sanofi India’s (SANL) Q3CY22 performance was below our estimates. Revenues declined 8.3% YoY to Rs6.9bn (I-Sec: Rs.7.7bn) due to weak performance in key brands.

Sanofi India Ltd. is trading below all available SMAs

Sanofi India Ltd.

04 Nov 2022

4036.80

0.67%

Sanofi India

Hold: Sanofi India Ltd.

Target

ICICI Direct

Number of FII/FPI investors decreased from 164 to 149 in Dec 2025 qtr

Sanofi India Ltd.

27 Jul 2022

4036.80

0.67%

Sanofi India

Hold: Sanofi India Ltd.

Target

ICICI Direct

Sanofi has lost -20.47% in the last 6 Months

Sanofi India Ltd.

27 Apr 2022

4036.80

0.67%

Sanofi India

Hold: Sanofi India Ltd.

ICICI Direct

Abbott India is one of the fastest growing listed MNC pharma companies in women's health, GI, metabolic, pain, CNS among others. We continue to believe in Abbott's strong growth track in power brands and capability in...